About AccenGen Therapeutics

About company

AccenGen Therapeutics, Inc. is an early-stage pharmaceutical company focused on developing products using soluble epoxide hydrolase (sEH) inhibitors (sEHI) for indications with inflammatory etiologies, highest unmet needs and largest markets. sEH technology has been studied with over 800+ academic publications and the team at AccenGen has played key roles in 400+ drug development programs. AccenGen is currently raising a seed round.